Whether differences in epigenetic modifications, immune tolerance development, other underlying processes, or several of these mechanisms together cause the decrease in clinical Cul hypersensitivity when individuals are exposed to allergen early-in-life still needs to be explored in detail to better understand the prominent regulatory routes preventing IgE-mediated allergies. This evidence concerns the gene IGHE and allergic disease.